OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Company registration number: 2977135 Charity registration number: 1049067

Wythenshawe Hospital Transplant Fund

(A company limited by guarantee)

Annual Report and Financial Statements

for the Year Ended 31 March 2023

Wythenshawe Hospital Transplant Fund

Contents

Reference and Administrative Details 1
Trustees' Report 2 to 4
Statement of Trustees' Responsibilities 5
Independent Examiner's Report 6
Statement of Financial Activities 7 to 8
Balance Sheet 9
Notes to the Financial Statements 10 to 19
Wythenshawe Hospital Transplant Fund Wythenshawe Hospital Transplant Fund
Reference and Administrative Details
Trustees Dr P Callan
D K Cornwall
N Eadie
S Fowler
E Mather
W Noble
R Venkateswaran
J Haworth
R Wood
M J Hill
Secretary L C Ellis
Charity Registration Number 1049067
Company Registration Number 2977135
The charity is incorporated in England and Wales.
Principal Office The Transplant Fund Office
Transplant Centre
Wythenshawe Hospital
Manchester
M23 9LT
Independent Examiner Maria Hallows BA (Econs), FCA, DCha
Chartered Accountant
Beever and Struthers
One Express
1 George Leigh Street
Manchester
M5 4DL
Solicitors: Addleshaw Goddard
One St Peter's Square
Manchester
M2 3DE
Bankers HSBC Bank plc
11 Stamford New Road
Altrincham
WA14 1BW
W H Ireland
11 St James's Square
Manchester
M2 6WH

Page 1

Wythenshawe Hospital Transplant Fund

Trustees' Report

The trustees, who are directors for the purposes of company law, present the annual report together with the financial statements of the charitable company for the year ended 31 March 2023.

Trustees and officers

The trustees and officers serving during the year and since the year end were as follows:

Trustees: Dr P Callan (appointed 22 June 2022) D K Cornwall N Eadie S Fowler E Mather W Noble R Venkateswaran J Haworth (appointed 30 January 2023) R Wood (appointed 30 January 2023) M J Hill (appointed 7 December 2023)

Objectives and activities

Objects and aims

In setting our objectives and planning our activities, the Trustees have given careful consideration to the Charity Commission’s general guidance on public benefit.

As determined by the charity's Memorandum and Articles of Association, the principal activity of the charity is to support the programme of heart and lung transplantation at Wythenshawe Hospital, Manchester, serving the North West of England. Whilst the NHS provides substantial funds for the transplant centre there is always a demand for state-of-the-art equipment or money to support pioneering treatments and research which the NHS is unwilling to fund. The charity plays a vital role by providing funds to accelerate the adoption of new procedures and by funding research which advances the technology surrounding transplantation, thus enabling the Wythenshawe Transplant Centre to remain at the forefront of excellence for the treatment of cardiac and lung disease.

The charity is in regular contact with Wythenshawe Hospital and receives funding requests from the hospital. The Board determines whether to meet these requests for funding. The charity does not enter into contractual relationships with suppliers of equipment and services. It only provides the agreed funding. The Trustees’ policy is to approve all major grants prior to commitment of funds. With the exception of minor funding of up to £5,000, which may be approved by the Chairman, decisions relating to the allocation of funds are reserved to the Board and cannot be delegated.

Public benefit

All the activities of the charity are undertaken to further public benefit.

The trustees confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission for England and Wales.

Page 2

Wythenshawe Hospital Transplant Fund

Trustees' Report

Achievements and performance

Voluntary donations, legacies and other trading activities raised a total of £131,443 (2022: £198,166), grant income of £Nil (2022: £5,000) and investment income on our investments and cash deposits generated £24,530 (2022: £16,834). This allowed the Trustees to continue the charity's support for most of the requests submitted to the charity. Achievements within this financial year include, £21,000 given towards recipients selected to represent GB at the World Transplant Games, as well as contributions towards recipients attending the British Transplant Games, a £5,265 provision for free TV access to all beds on the Jim Quick Ward, a £3,249 purchase of Spirometers for use with our Lung recipients in Outpatients, and finally £27,245 spent on the purchase of more sherpa packs used for the transportation of Donor Hearts.

Financial review

The results for the year and their impact on the Charity's funds are set out in detail in the Statement of Financial Activities. Total net income for the year was £94,195 (2022: £155,495) and the year end net assets amounted to £1,435,393 (2022: £1,341,198), including £1,444,152 (2022: £1,202,726) in cash at the bank or invested in UK Government Stocks, corporate bond funds and Open Ended Investment Companies.

Policy on reserves

The charity's reserves are represented by its investments and cash balances. The Trustees have reviewed the charity’s requirements for unrestricted reserves in the light of the main risks to the organisation. In the opinion of the Trustees, sufficient unrestricted reserves are required to meet one year’s operating costs in the event of a significant drop in incoming resources and £50,000 is considered to be adequate for this purpose. The balance of the unrestricted reserves are free reserves and are available to be used to fund projects in accordance with the charity's objects.

At 31 March 2023 the unrestricted reserves were £1,422,039 (2022: £1,324,184). The trustees consider that the reserves held at the year end are above target level.

Investment policy and objectives

The Trustees are empowered to invest and deal with the monies of the charity not immediately required in such a manner as the charity may from time to time determine subject to such conditions and consents imposed or required by law. Surplus funds are placed on deposit either with the charity's bankers or with W H Ireland Ltd or invested in UK Government Stocks, corporate bond funds and unit trusts. Investment returns are governed by the prevailing interest rates and dividend payments.

Structure, governance and management

Recruitment and appointment of trustees

No person may be appointed as a Trustee unless approved by all the Trustees. At every general meeting one third of the Trustees retire by rotation being decided by the length of time in office. Subject to the above, University Hospital of South Manchester NHS Foundation Trust (now Manchester University NHS Foundation Trust) may appoint one Trustee. Trustees must be aged 18 years or above and not disqualified by reason of Article 10.1 of the charity's Articles of Association or in company or charity law. None of the Trustees have any interest in the charity. Trustees are appointed under the provision of Articles 31 to 33 of the charity's Articles of Association.

Induction and training of trustees

All new Trustees receive a formal briefing from the Chairman of their duties and responsibilities and receive various booklets from the Charity Commission and Companies House. Trustees are also encouraged to keep themselves abreast of current and proposed developments in charity regulation through access to the Charity Commission website and other relevant sources of information.

Page 3

Wythenshawe Hospital Transplant Fund

Trustees' Report

Major risks and management of those risks

The Trustees continue to review the charity's activities to identify the major risks to which it is exposed and the systems established to mitigate risks are periodically reviewed to ensure that they are operating effectively and still meet the needs of the charity. It has been determined that the principal risks and uncertainties are the volatility of investments held by the charity and the continued ability to raise voluntary income. The steps taken by the Trustees to mitigate these risks as far as practicable are to maintain and regularly review a diversified portfolio of investments, to maintain sufficient cash reserves and to monitor both investment performance and the level of voluntary income received at each Board meeting.

Small companies provision statement

This report has been prepared in accordance with the small companies regime under the Companies Act 2006.

The annual report was approved by the trustees of the charity on 29 January 2024 and signed on its behalf by:

......................................... D K Cornwall Trustee

Page 4

Wythenshawe Hospital Transplant Fund

Statement of Trustees' Responsibilities

The trustees (who are also the directors of Wythenshawe Hospital Transplant Fund for the purposes of company law) are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".

Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including its income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records that can disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Approved by the trustees of the charity on 29 January 2024 and signed on its behalf by:

----- Start of picture text -----
.........................................
D K Cornwall
Trustee
----- End of picture text -----

Page 5

Wythenshawe Hospital Transplant Fund

Independent Examiner's Report to the trustees of Wythenshawe Hospital Transplant Fund ('the Company')

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2023.

Responsibilities and basis of report

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner’s statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of Wythenshawe Hospital Transplant Fund as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view' which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

......................................

Maria Hallows BA (Econs), FCA, DCha Chartered Accountant

Beever and Struthers One Express 1 George Leigh Street Manchester M5 4DL

Date:.............................30 January 2024

Page 6

Wythenshawe Hospital Transplant Fund

Statement of Financial Activities for the Year Ended 31 March 2023 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)

Note
Income and Endowments from:
Donations and legacies
3
Other trading activities
4
Investment income
5
Total income
Expenditure on:
Raising funds
6
Charitable activities
7
Total expenditure
Gains/losses on investment assets
Net income/(expenditure)
Net movement in funds
Reconciliation of funds
Total funds brought forward
Total funds carried forward
17		 Unrestricted
funds
£
101,230
30,213
24,530
155,973
(8,969)
(10,885)
(19,854)
(38,264)
97,855
97,855
1,324,184
1,422,039		 Restricted
funds
£
-
-
-
-
-
(3,660)
(3,660)
-
(3,660)
(3,660)
17,014
13,354		 Total
2023
£
101,230
30,213
24,530
155,973
(8,969)
(14,545)
(23,514)
(38,264)
94,195
94,195
1,341,198
1,435,393

The notes on pages 10 to 19 form an integral part of these financial statements. Page 7

Wythenshawe Hospital Transplant Fund

Statement of Financial Activities for the Year Ended 31 March 2023 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)

Note
Income and Endowments from:
Donations and legacies
3
Other trading activities
4
Investment income
5
Total income
Expenditure on:
Raising funds
6
Charitable activities
7
Total expenditure
Gains/losses on investment assets
Net income
Net movement in funds
Reconciliation of funds
Total funds brought forward
Total funds carried forward
17		 Unrestricted
funds
£
136,928
60,598
16,834
214,360
(8,038)
(75,622)
(83,660)
20,059
150,759
150,759
1,173,425
1,324,184		 Restricted
funds
£
5,640
-
-
5,640
-
(904)
(904)
-
4,736
4,736
12,278
17,014		 Total
2022
£
142,568
60,598
16,834
220,000
(8,038)
(76,526)
(84,564)
20,059
155,495
155,495
1,185,703
1,341,198

All of the charity's activities derive from continuing operations during the above two periods. The funds breakdown for 2022 is shown in note 17.

The notes on pages 10 to 19 form an integral part of these financial statements. Page 8

Wythenshawe Hospital Transplant Fund

(Registration number: 2977135) Balance Sheet as at 31 March 2023

Note
Current assets
Stocks
12
Debtors
13
Investments
14
Cash at bank and in hand
15
Creditors: Amounts falling due within one year
16
Net assets
Funds of the charity:
Restricted income funds
Restricted funds
Unrestricted income funds
Unrestricted funds
Total funds
17		 2023
£
200
178
520,355
923,797
1,444,530
(9,137)
1,435,393
13,354
1,422,039
1,435,393		 2022
£
200
240,324
551,809
650,917
1,443,250
(102,052)
1,341,198
17,014
1,324,184
1,341,198

For the financial year ending 31 March 2023 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements on pages 7 to 19 were approved by the trustees, and authorised for issue on 29 January 2024 and signed on their behalf by:

----- Start of picture text -----
.........................................
D K Cornwall
Trustee
----- End of picture text -----

The notes on pages 10 to 19 form an integral part of these financial statements. Page 9

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

1 Charity status

The charity is a private company limited by guarantee, incorporated in England and Wales, and consequently does not have share capital. Each of the trustees is liable to contribute an amount not exceeding £1 towards the assets of the charity in the event of liquidation.

The address of its registered office is: The Transplant Fund Office Transplant Centre Wythenshawe Hospital Manchester M23 9LT

2 Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) (issued in October 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Basis of preparation

Wythenshawe Hospital Transplant Fund meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern nor any significant areas of uncertainty that affect the carrying value of assets held by the charity.

Critical accounting judgements and key sources of estimation uncertainty

The preparation of the financial statements in conformity with FRS 102 requires the use of certain critical accounting estimates. It can also require the Trustees to exercise their judgement in the process of applying the charity's accounting policies. The charity is not considered to have any critical accounting estimates or judgements at this time.

Income and endowments

All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of the income receivable can be measured reliably.

Page 10

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

Donations and legacies

Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In the event that a donation is subject to conditions that require a level of performance by the charity before the charity is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those conditions is wholly within the control of the charity and it is probable that these conditions will be fulfilled in the reporting period.

Legacy gifts are recognised on a case by case basis following the grant of probate when the administrator/executor for the estate has communicated in writing both the amount and settlement date. In the event that the gift is in the form of an asset other than cash or a financial asset traded on a recognised stock exchange, recognition is subject to the value of the gift being reliably measurable with a degree of reasonable accuracy and the title to the asset having been transferred to the charity.

Grants receivable

Grants are recognised when the charity has an entitlement to the funds and any conditions linked to the grants have been met. Where performance conditions are attached to the grant and are yet to be met, the income is recognised as a liability and included on the balance sheet as deferred income to be released.

Investment income

Dividends are recognised once the dividend has been declared and notification has been received of the dividend due.

Expenditure

All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. Other support costs are allocated based on the spread of staff costs.

Raising funds

These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds.

Charitable activities

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.

Taxation

The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

Current asset investments

Current asset investments are included at the lower of cost and net realisable value / market value.

Page 11

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

Stock

Stock is valued at the lower of cost and estimated selling price less costs to complete and sell, after due regard for obsolete and slow moving stocks. Cost is determined using the first-in, first-out (FIFO).

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the charity will not be able to collect all amounts due according to the original terms of the receivables.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Fund structure

Unrestricted income funds are general funds that are available for use at the trustees discretion in furtherance of the objectives of the charity.

Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is restricted to that area or purpose.

Financial instruments

Classification

Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities.

Page 12

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

Recognition and measurement

All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Financial assets and liabilities are only offset in the statement of financial position when, and only when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Financial assets are derecognised when and only when a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or c) the charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires.

3 Income from donations and legacies

Donations and legacies;
Donations from individuals
Legacies
In memoriam
Donations and legacies;
Donations from individuals
Legacies
In memoriam
Grants, including capital grants;
Grants from companies		 Unrestricted
funds
General
£
45,264
64,991
26,673
-
136,928		 Unrestricted
funds
General
£
43,627
35,226
22,377
101,230
Restricted
funds
£
640
-
-
5,000
5,640		 Total
2023
£
43,627
35,226
22,377
101,230
Total
2022
£
45,904
64,991
26,673
5,000
142,568

Page 13

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

4 Income from other trading activities

Trading income;
Income from sales of merchandise
Fundraising events
5
Investment income
Interest receivable and similar income;
Interest receivable on bank deposits
Other investment income		 Unrestricted
funds
General
£
1,949
28,264
30,213
Unrestricted
funds
General
£
2,459
22,071
24,530		 Total
2023
£
1,949
28,264
30,213
Total
2023
£
2,459
22,071
24,530		 Total
2022
£
3,792
56,806
60,598
Total
2022
£
59
16,775
16,834

6 Expenditure on raising funds

a) Costs of trading activities

Costs of goods sold Unrestricted
funds
General
£
2,492
2,492		 Total
2023
£
2,492
2,492		 Total
2022
£
3,117
3,117

Page 14

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

b) Investment management costs

Finance charges;
Bank charges
Other investment management costs;
Amounts payable to investment managers
7
Expenditure on charitable activities
Medical supplies / equipment
Refurbishment costs
Other charitable donations
Administration and other costs
Staff costs
Medical supplies / equipment
Other charitable donations
Administration and other costs
Staff costs		 Unrestricted
funds
General
£
227
6,250
6,477
Unrestricted
funds
General
£
63,223
(89,719)
1,270
13,742
22,369
10,885
Unrestricted
funds
General
£
39,225
2,074
10,958
23,365
75,622		 Total
2023
£
227
6,250
6,477
Restricted
funds
£
-
-
3,660
-
-
3,660
Restricted
funds
£
-
-
904
-
904		 Total
2022
£
140
4,781
4,921
Total
2023
£
63,223
(89,719)
4,930
13,742
22,369
14,545
Total
2022
£
39,225
2,074
11,862
23,365
76,526

Page 15

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

8 Net incoming/outgoing resources

Net incoming resources for the year include:

Finance charges payable
Independent Examiners Fee		 2023
£
227
2,340		 2022
£
140
2,340

9 Trustees remuneration and expenses

No trustees, nor any persons connected with them, have received any remuneration from the charity during the year.

No trustees have received any reimbursed expenses or any other benefits from the charity during the year.

10 Staff costs

The aggregate payroll costs were as follows:

Staff costs during the year were:
Wages and salaries
Pension costs
The monthly average number of persons (including senior management /
charity during the year expressed as full time equivalents was as follows:
Administrative Staff
No employee received emoluments of more than £60,000 during the year.
11 Taxation
The charity is a registered charity and is therefore exempt from taxation.
12 Stock
Stocks		 2023
£
2022
£
21,074
21,750
1,295
1,615
22,369
23,365
leadership team) employed by the
2023
No
2022
No
1
1
2023
£
2022
£
200
200		 2022
£
21,750
1,615
23,365
2022
£
200

Page 16

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

13 Debtors

Legacies receivable
Prepayments
Other debtors
14 Current asset investments
Listed other shares
15 Cash and cash equivalents
Cash at bank
16 Creditors: amounts falling due within one year
Other taxation and social security
Accruals		 2023
£
-
177
1
178
2023
£
520,355
2023
£
923,797
2023
£
545
8,592
9,137		 2022
£
231,139
184
9,001
240,324
2022
£
551,809
2022
£
650,917
2022
£
1,642
100,410
102,052

Page 17

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

17 Funds

Unrestricted funds
General
Restricted funds
Total funds
Unrestricted funds
General
Restricted funds
Total funds		 Balance at 1
April 2022
£
1,324,184
17,014
1,341,198
Balance at 1
April 2021
£
1,173,425
12,278
1,185,703		 Incoming
resources
£
155,973
-
155,973
Incoming
resources
£
214,360
5,640
220,000		 Resources
expended
£
(19,854)
(3,660)
(23,514)
Resources
expended
£
(83,660)
(904)
(84,564)		 Other
recognised
gains/(losses)
£
(38,264)
-
(38,264)
Other
recognised
gains/(losses)
£
20,059
-
20,059		 Balance at
31 March
2023
£
1,422,039
13,354
1,435,393
Balance at
31 March
2022
£
1,324,184
17,014
1,341,198

The specific purposes for which the funds are to be applied are as follows:

The restricted income funds comprise amounts given by donors who indicate that their donations are to be spent on specific items to be used, or projects to be carried out, at Wythenshawe Hospital to further the objects of the charity. The balance at the year end can be split between equipment for hearts £4,090 (2022: £4,090), expenditure for the bungalows £7,923 (2022: £7,923), educational grant £1,340 (2022: £5,000).

Page 18

Wythenshawe Hospital Transplant Fund

Notes to the Financial Statements for the Year Ended 31 March 2023

18 Analysis of net assets between funds

18 Analysis of net assets between funds
Current assets
Current liabilities
Total net assets
Current assets
Current liabilities
Total net assets		 Unrestricted
funds
General
£
1,431,176
(9,137)
1,422,039
Unrestricted
funds
General
£
1,431,236
(102,052)
1,329,184		 Restricted
funds
£
13,354
-
13,354
Restricted
funds
£
17,014
-
17,014		 Total funds at
31 March
2023
£
1,444,530
(9,137)
1,435,393
Total funds at
31 March
2022
£
1,448,250
(102,052)
1,346,198

19 Related party transactions

There were no related party transactions in the year.

Page 19